lecture_headache
TRANSCRIPT
-
8/7/2019 lecture_headache
1/54
ea ac e
Jennifer McCombe
-September 15, 2006
-
8/7/2019 lecture_headache
2/54
Overview
Basics of headache S ecific headache
Epidemiology Anatomy
disorders Thunderclap headache
Diagnostic work-up
thrombosis
Cervical artery dissection gra ne
Trigeminal neuralgia
Post LP headache
Idiopathic intracranialhypertension
Chronic dail headache
-
8/7/2019 lecture_headache
3/54
Epidemiology
Headache is the resentin s m tom in 1-2.5% of
emergency visits Patients present to the emergency with 2 types of
1. First or worst syndrome
2. Last straw syndrome
medical specialties
Most headaches dont re resent a serious medical
condition However, has one of the longest lists of differential
-
8/7/2019 lecture_headache
4/54
Anatomy
Pain sensitive structures include:
Skin and its blood supply Muscles of the head and neck
Portions of the meninges including the dura mater at the
base of the skull ura ar er es
Intracerebral arteries
Cervical nerves
Select cranial nerves
Pain sensitive structures are affected by tension,, , ,
-
8/7/2019 lecture_headache
5/54
Evaluation
based on the International Headache Societyclassification s stem u dated in 2003
Headache divided into two main types: Primary
and secondary
The most important diagnostic tool is a
detailed history
Diagnostic tests only help to establish or
exclude causes of secondar headache
-
8/7/2019 lecture_headache
6/54
Evaluation
Histor : Past headache histor
Onset Duration
(including meds tried) Past medical history
Course
Character
e ca ons
Family history Severity
Location
Associated s m toms
alcohol and drugs,sleep, eating and
Precipitants or triggers
Prodromes
exerc se a s, owheadache affectsfunction)
-
8/7/2019 lecture_headache
7/54
Evaluation
diary documenting headaches, possibletri ers and treatment tried is often ver
helpful in clarifying details of the history
-
8/7/2019 lecture_headache
8/54
Evaluation
KEY POINTS: Vitals
Fundoscopy
Palpation of areas of head and neck Auscultation of eyes, neck
Nuchal rigidity and meningeal signs
-
8/7/2019 lecture_headache
9/54
Further evaluation of headache
-
8/7/2019 lecture_headache
10/54
Further evaluation of headache
-
8/7/2019 lecture_headache
11/54
When to consider neuroimaging Temporal profile and headache features:
1. e rs or wors ea ac e un erc ap ea ac e
2. Subacute headache with increasing frequency or severity3. Progressive or new daily persistent headache
4. Chronic daily headache
5. Side-locked
6. Headache not responding to treatment
Demo ra hics:1. New headache in patient with cancer or HIV
2. New headache age > 50
3. Headache and seizures
Associated symptoms and signs:1. Fever, stiff neck, nausea and vomiting
2. Focal neurological symptoms or signs
3. Papilledema, cognitive impairment or personality change
-
8/7/2019 lecture_headache
12/54
Overview
Basics of headache S ecific headache
Epidemiology Anatomy disorders Thunderclap headache
Diagnostic work-up
thrombosis
Cervical artery dissection gra ne
Trigeminal neuralgia
Post LP headache
Idiopathic intracranialhypertension
Chronic dail headache
-
8/7/2019 lecture_headache
13/54
Thunderclap headache
onset
associated with subarachnoid hemorrhage
If the work-up for SAH is negative, however,
etiology
-
8/7/2019 lecture_headache
14/54
Causes of thunderclap headache
-
8/7/2019 lecture_headache
15/54
Subarachnoid hemorrhage
thunderclap headache and should be thefocus of the initial investi ations
11-25% of patients presenting with thunderclap
headache have SAH
Etiology of SAH:
Ruptured aneurysm 85%
Non aneurysmal perimesencephalic bleed 10%
Other causes 5%
-
8/7/2019 lecture_headache
16/54
Subarachnoid hemorrhage
minutes
days
-
isolated headache
-have a history of a sentinel headache days to
-
8/7/2019 lecture_headache
17/54
Subarachnoid hemorrhage
Sensitivity with new scanners nears 100% withinthe first 12 hours
This is provided that the images are interpreted by an
experienced neuroradiologist (or Dr. Mike Saka) ens v y a s o y wee
Therefore, in cases where clinical suspicion
s g , nee an o ru e ou LP needs to be analyzed for xanthochromia
-
8/7/2019 lecture_headache
18/54
-
8/7/2019 lecture_headache
19/54
Cerebral venous sinus thrombosis
onset exacerbated by increases inintracranial ressure that occur with
coughing, sneezing, and valsalva
-
Up to 10% of patients can present with a
-
8/7/2019 lecture_headache
20/54
Cerebral venous sinus thrombosis
CT head:
Normal exam: CT normal 25% of the time Abnormal exam: CT normal 10% of the time
LP can have subtle abnormalities (RBC, protein,
mild lymphocytic pleocytosis, opening pressure) ere ore, one nee s a g n ex o susp c on
especially in women who are pregnant or post-
artum in atients with a histor of DVT
Requires an MRI with MRV to establish or exclude
the diagnosis
-
8/7/2019 lecture_headache
21/54
-
8/7/2019 lecture_headache
22/54
Cervical artery dissection
Most commonl associated with a headache of
subacute onset 20% of patients present with a thunderclap
Headache reported by 60-95% of patients with
carotid arter dissection and 70% of atients withvertebral artery dissection
Headache generally ipsilateral to the dissection and
, , , ,temporal regions; with neck pain in 25-50% ofpatients
-
8/7/2019 lecture_headache
23/54
Cervical artery dissection
neurological symptoms is 4 days with carotiddissection and 14.5 hours with vertebral
artery dissection
with a history of TIA or stroke and a history of
trauma or chiro ractic mani ulation
-
8/7/2019 lecture_headache
24/54
-
8/7/2019 lecture_headache
25/54
Migraine
predisposition to headaches, GI dysfunction,and neurolo ical d sfunction
Inherited in an autosomal dominant fashion
encountered; triggers include hormonal
, , , ,
alcohol, smells, sleep disturbance etc
-
8/7/2019 lecture_headache
26/54
Migraine
,
throbbing, worse with activity and associatedwith nausea vomitin hoto hobia and
sonnophobia
that the HIS criteria are too strict
-
8/7/2019 lecture_headache
27/54
Migraine
Princi les of Treatment:
Goal is to stop headache and progression of the pain Are treatment options which are migraine specific and
ose w c are non-spec c
Is best to treat early in the course of the headache to
prevent central sensitization and treatment refractory pain
Use different agents for different intensities of pain and limit
abortive therapies to 2 times per week to avoid medication
If requiring more frequent abortive therapies need to
recommend prophylaxis
-
8/7/2019 lecture_headache
28/54
Migraine
Treatment of the acute headache NSAIDs
Hydration/ iv fluids Triptans
the coronary arteries therefore contraindicated in those with a historyof CAD
DHE os common s e e ec s nausea ere ore pre rea w an
antiemetic
Neuroleptics (metoclopromide, promethazine, prochlorperazine,chlorpromazine)
Can cause hypotension when given iv therefore give with saline Corticosteroids
Used in status migrainosis
-
8/7/2019 lecture_headache
29/54
Trigeminal Neuralgia
The most common cranial neuralgia
More common in women with an average age ofonset at 50 years
Characterized by brief lancinating pain limited to the
distribution of one or more divisions of the trigeminal,
Pain intensity is excruciating, described as sudden,sharp, superficial, stabbing or burning
Paroxysmal and usually lasts a few seconds May occur in volleys with pain free periods lasting
seconds to hours
-
8/7/2019 lecture_headache
30/54
Trigeminal Neuralgia
Painful e isodes associated with tri er
zones around the mouth and nostril Can be tri ered b wind on the face,
brushing teeth, shaving, chewing or even
talking Majority of cases are idiopathic
Suspicion of a secondary cause should arise
w en a c ron c con nuous pa n s punc ua eby paroxysms of pain or when the is signs of
-
8/7/2019 lecture_headache
31/54
Trigeminal Neuralgia
Diagnosis in younger patients should prompt
MS, posterior fossa tumours, or aneurysmal
10% of patients harbour an intracranial lesion
patients
-
8/7/2019 lecture_headache
32/54
Trigeminal Neuralgia
Treatment:
Spontaneousremissions are
common
After 8 weeks of
,slow drug taper is
recommended
-
8/7/2019 lecture_headache
33/54
Trigeminal Neuralgia
Approximately 30% of patients will fail medicalthera and ma re uire sur ical or ablative
procedures
Microvascular decompression is considered to bethe definitive process for idiopathic trigeminal
neuralgia
-
8/7/2019 lecture_headache
34/54
-
8/7/2019 lecture_headache
35/54
Post LP headache
Defined as a bilateral headache that
develops within 7 days after LP anddisappears within 14 days after LP
Headache worsens within 15 minutes of
assuming the upright position and disappearsor mproves w n m nu es o resum ngthe recumbent position
areas, and may also involve the neck andu er shoulders
-
8/7/2019 lecture_headache
36/54
Post LP headache
,
vomiting, visual disturbances, and hearingalteration
Visual symptoms most commonly due to 6th
10% of patients with LP have some alteration
,
range
-
8/7/2019 lecture_headache
37/54
Post LP headache
The fre uenc of headache is inversel related to
age The greatest influence on the incidence is technique
and choice of needle
Ensuring the direction of the bevel is parallel to the
headache
Smaller needles also have a lower incidence of headache
Many recommend bedrest following dural puncturehowever, studies do not support this
-
8/7/2019 lecture_headache
38/54
Post LP headache
Treatment:
Conservative measures: Bedrest
Analgesia
Hydration
Caffeine Sumatriptan
Autologous epidural blood patch
g success ra e, ow comp ca on ra e Performing the blood patch too early increases the risk
of failure; optimal time is 24 hours post LP
-
8/7/2019 lecture_headache
39/54
-
8/7/2019 lecture_headache
40/54
Idiopathic Intracranial Hypertension
Condition of increased intracranial ressure without
clinical, laboratory, or radiological evidence ofintracranial pathology
Typical patient is an obese, but otherwise healthy
woman of childbearing age with symptoms of
Seen in all ages with an incidence of 21:100000
- , .
Is a diagnosis of exclusion
-
8/7/2019 lecture_headache
41/54
Idiopathic Intracranial Hypertension
Etiolo and atho enesis are unknown
Symptoms include headache, pulsatile tinnitus,transitory visual obscurations, nausea, blurred vision
and diplopia
Headache is episodic in onset and usually developsover wee s o a y pa n o mo era e n ens y,
worse in the morning and during physical activity,
with valsalva maneuvres and with ostural chan es
Quality and location of the headache are non-
specific
-
8/7/2019 lecture_headache
42/54
Idiopathic Intracranial Hypertension
E isodes of visual obscurations can be monocularor binocular and usually last less than a minute
Episodes are provoked by postural changes and the
No way to predict those at risk of developing
ermanent visual deficits Transient sixth nerve palsy is the most common
cause of episodes of diplopia
er, ess common symp oms exper ence nc u etransient sensory symptoms, decreasedconcentration and memory difficulties
-
8/7/2019 lecture_headache
43/54
Idiopathic Intracranial Hypertension
On examination, one usually sees bilateralpapilledema (blurring of the disc border, absent
venous pulsations, distended retinal veins, and laterprotrusion of the optic disc, peripapillary
emorr ages an exu a es
The risk of permanent deficit increases with the
duration of edema Transient visual field deficits occur in 96% of
patients; enlargement of the blind spot being themost fre uent
Defect is usually asymptomatic and resolves whenthe edema resolves
-
8/7/2019 lecture_headache
44/54
Idiopathic Intracranial Hypertension
Measurement of CSF ressure necessar for
diagnosis For accurate measurement, needs to be assessed in the
a era ecu us pos on w egs ex en e an as
relaxed as possible
Pressure readings between 200 and 250 mm are a non-diagnostic grey zone
93% of patients have an elevated, steady state,
pressure monitoring to catch transient pathological
elevations in ressure
-
8/7/2019 lecture_headache
45/54
Idiopathic Intracranial Hypertension
CSF analysis within normal limits by definition
be carried out before the diagnosis of
given
-
8/7/2019 lecture_headache
46/54
Idiopathic Intracranial Hypertension
Treatment
Symptomatic: focused on lowering ICP and preventingpermanent visual deficits and headache
nc u es:
1. Weight loss
2. Acetazolamide (carbonic anhydrase inhibitor)3. Furosemide
4. Topiramate
.
6. Surgical options: shunting and optic nerve sheet fenestration
7. Controversial: repeated lumbar punctures
-
8/7/2019 lecture_headache
47/54
Idiopathic Intracranial Hypertension
Pro nosis: Spontaneous recovery is common
Cessation of symptoms in 70-85% of patients within 2-3
Up to 25% have a more protracted course
Recurrence not unusual (10-40%)
ery s g permanen v sua e e c s common normaformal testing in only 43% of patients) but largelyasymptomatic
o pa en s exper ence severe permanen v sua edeficits
Up to 5% develop blindness in one or both eyes
-
8/7/2019 lecture_headache
48/54
h d l h d h
-
8/7/2019 lecture_headache
49/54
Chronic daily headache
Refers to the resence of headache for more than
15 days per month for longer than 3 months
Is a category that contains many disorders
representing primary and secondary headaches
70-80% of patients presenting to headache clinics
ave a y or near- a y ea ac es
Transformed migraine and medication-overuse
Ch i d il h d h
-
8/7/2019 lecture_headache
50/54
Chronic daily headache
Risk factors include obesit a histor of fre uentheadache (more than 1 per week), caffeine
consumption, and overuse (more than 10 days per,
analgesics, ergots, and triptans
Greater than 50% of patients have sleepdisturbances and mood disorders
Most patients with transformed migraine are women,,
transformation in which the headaches becamemore frequent until the current pattern developed
Ch i d il h d h
-
8/7/2019 lecture_headache
51/54
Chronic daily headache
Reasons to ima e:
1. Development of progressively frequent and severe
headache within a period of 3 months
2. euro og c symp oms
3. Focal or lateralizing neurologic signs
4. Pa illedema5. Headaches aggravated or relieved by assuming an
upright or supine posture
6. ea ac es provo e y a sa va
7. Systemic symptoms or fever
8. Histor of new headache after the a e of fift
Ch i d il h d h
-
8/7/2019 lecture_headache
52/54
Chronic daily headache
In medication overuse headaches there are var inintervals from the time of frequent intake of
medications to the development of chronic daily
Triptans: 1.7 years
Ergots: 2.7 years
Simple analgesics: 4.8 years
Accurate diagnosis and treatment requires thewithdrawal of these medications if an e isodic
pattern of headache recurs within 2 months ofwithdrawal, medication-overuse headache is
Ch i d il h d h
-
8/7/2019 lecture_headache
53/54
Chronic daily headache
Treatment strate ies:
Lifestyle modification: Limiting caffeine consumption
Regular exercise
Regular mealtimes
Re ular slee schedule Preventative medications:
Tricyclic antidepressants, low dose
a apen n
Topiramate, low dose
Botulinum toxin type A
Ch i d il h d h
-
8/7/2019 lecture_headache
54/54
Chronic daily headache
medications, there are a few strategies tolimit withdrawal s m toms
Use NSAIDS and DHE to treat breakthrough
headaches as these are considered at lower riskof medication overuse headache
Prednisone 100 mg daily for 5 days may reduce
e num er o ours o severe w rawa
headache (Pageler et al., 2004)